JEMO-PHARM A/S: Financial statements 2024
CVR: 10216109
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
JEMO-PHARM A/S (CVR 10216109) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 4,098,000 and a net result of DKK -8,629,000 compared with DKK -560,000 the year before. That is a decrease of 66.8% compared with the year before. Equity in the 2024 report amounted to DKK -8,789,000. The company had 29 employees in the financial year.
- Gross Profit
- DKK 4,098,000
- Profit/Loss
- DKK -8,629,000
- Equity
- DKK -8,789,000
- Total Assets
- DKK 38,507,000
- Employees
- 29
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 4.1 mio. | -8.6 mio. | -8.8 mio. | 29 |
| 2023 | - | 12.3 mio. | -560 t. | -160 t. | 32 |
| 2022 | - | 10.1 mio. | -930 t. | -364 t. | 29 |
| 2021 | - | 11.5 mio. | 166 t. | 566 t. | 28 |
| 2020 | - | 8.6 mio. | -2.8 mio. | 400 t. | 24 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
JEMO-PHARM A/S has published its annual report for 2023. Gross profit came to DKK 12,326,000, and the net result was DKK -560,000.
About JEMO-PHARM A/S
JEMO-PHARM A/S is a Danish company of the type Aktieselskab based in Stege, founded in 1986. The company is registered under the industry Fremstilling af andre fødevarer i.a.n.. The company was previously named CMA TERADATA A/S and TERADATA A/S. The management consists of Mikael Andreas Mohr. The board consists of Svend Aage Dreist Hansen (chair), Henrik Winther Olsen and Mikael Andreas Mohr. The company is owned by THE WHOLE COMPANY A/S and MAM Invest ApS. The company has 31 employees (2026). In 2025, the company reported a gross profit of DKK 11,929,000 and a net result of DKK 30,000 compared with DKK -8,629,000 the year before. Equity in the 2025 report amounted to DKK 10,041,000.